Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AQXP

Aquinox Pharmaceuticals (AQXP) Stock Price, News & Analysis

Aquinox Pharmaceuticals logo

About Aquinox Pharmaceuticals Stock (NASDAQ:AQXP)

Advanced Chart

Key Stats

Today's Range
$21.22
$22.66
50-Day Range
$3.68
$4.03
52-Week Range
$2.00
$3.84
Volume
89,846 shs
Average Volume
239,362 shs
Market Capitalization
$530.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AQXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aquinox Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AQXP Stock News Headlines

Mirum Pharmaceuticals, Inc. (MIRM)
Why Aquinox Pharma (AQXP) Stock Might be a Great Pick
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

AQXP Stock Analysis - Frequently Asked Questions

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) announced its quarterly earnings results on Thursday, November, 8th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.43.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aquinox Pharmaceuticals investors own include Novavax (NVAX), Bausch Health Cos (BHC), Sarepta Therapeutics (SRPT), ACADIA Pharmaceuticals (ACAD), XOMA Royalty (XOMA), Alnylam Pharmaceuticals (ALNY) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2018
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AQXP
CIK
1404644
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.58 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.13%
Return on Assets
-28.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
63.17
Quick Ratio
63.17

Sales & Book Value

Annual Sales
$25 million
Price / Sales
21.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.09 per share
Price / Book
7.29

Miscellaneous

Outstanding Shares
23,540,000
Free Float
N/A
Market Cap
$530.59 million
Optionable
Not Optionable
Beta
-7.37
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AQXP) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners